i would agree with your position except for Dr. Recknor's comments before Christmas that the topline NASH report would be completed before the holidays . I dont get the impression he is loose with dates and there is a reason he is sitting on the results. even if our silence right now is purely financial with our cash position and the Amarex issue , there is no reason to sit on that topline report... the other piece is the removal of NP and the addition of the new COB i dont think Dr. Kelly would have removed himself as Chairman, a role that the new COB has been in since November based on her Linkedin. could the silence purely be a financial situation ? yes and of course im speculating also. but when i add up all the loose ends, with only a few mentioned here, i am still leaning to a partnership arrangement in 2022 by a party who will buy Cytodyn in a couple of years...